(Q57591255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

7

M J Ratain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

A M Mauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G F Fleming

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D Bertucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Rotmensch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R H Jacobs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1743-1747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Phase II study of liposomal doxorubicin in advanced gynecologic cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013574328938

7 January 2021

Identifiers

DOI

10.1023/A:1013574328938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843253%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference